About Us

LITMUS Molecular Design is a subsidiary of LITMUS, LLC, a global technology innovation company.  Our focus is on using LITMUS Spectral Modeling, the application of its patented methodology (Spectral Data Activity Relationship) to dramatically reduce the time and cost of commercializing new molecular entities. LITMUS Molecular Design provides to its customers both products and services:

• LITMUS Molecular Analysis Services (L-MAS).

Solutions related to undesirable and/or desirable product characteristics for customer-identified compounds (e.g., toxicity prediction/ranking, information to support modification of existing compounds to improve efficacy/reduce toxicity),

• LITMUS Molecular Entity Design (L-MED).

Using Spectral Modeling to design new chemical entities for out-licensing or direct sale.

LITMUS Molecular Design provides custom solutions to specific problems. LMD is customer focused, delivering products and services that exceed its customer's expectations.